SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorSeoul National University Hospital

About this trial

To test the effects of home-based care on unplanned hospitalization within 6 months among advanced cancer patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-ups.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient

A person who has an advanced-stage solid cancer diagnosis (ICD-10 code C00-C70); A person who is receiving or planning to receive cancer treatment

A person who meets one of the following conditions

Has been evaluated as having ECOG performance status 2

Disqualifiers

Patient

A person who cannot speak, hear, or read Korean

A person who is judged by a medical doctor to be unable to take part in this research due to extremely poor health

A person residing outside the range that can be visited by the respective medical institution (the conditions for distance are to be specified by each medical institution)*

Trial design

Design model

Parallel

Treatments tested in this trial

  • Home-based care

    Other intervention

    Home-based medical care is based on a specialized home-based medical team approach, including following: 1. Specialized Home-Based Medical Team Approach 2. Initial Assessment and Education 3. Initial Home Visits and Education 4. Multidisciplinary Team Meeting 5. Regular Assessment After the Initial Visit

Treatment groups

396 Participants
are divided into 2 treatment groups
Group A: InterventionExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Unplanned hospitalization

1. admission to the enrolled hospital to treat unexpected symptoms or medical conditions (not including planned admission for chemotherapy or admission for planned surgery or intervention) 2. admission to a hospital other than the enrolled hospital 3. admission to a nursing hospital for a duration of less than 4 weeks.

Time frame
within 6 months following enrollment

Secondary outcomes

1

Patient medical utilization

The total number of hospital utilization, including hospitalization, emergency room visit, and clinic visits

Time frame
within 6 months following enrollment
2

Hospitalization

the number of hospitalization

Time frame
within 6 months following enrollment
3

ER visits

the number of emergency room visits

Time frame
within 6 months following enrollment
4

Healthcare use

the number of healthcare use for severe diseases

Time frame
within 6 months following enrollment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Seoul National University Hospital

Lead sponsor

Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Collaborator

DongGuk University

Collaborator

Kyung Hee University Hospital

Collaborator

Bundang CHA Hospital

Collaborator

Seoul National University Bundang Hospital

Collaborator